Cargando…
Lacosamide induced Brugada I morphology in the setting of septicemia: A case report
INTRODUCTION: Brugada syndrome may be unmasked by non-antiarrhythmic pharmaceuticals or drugs. Lacosamide is an antiepileptic agent with a novel mechanism of sodium channel inhibition and has the potential to cause cardiac sodium channel blockade. PATIENT CONCERNS: In this report, we describe the ca...
Autores principales: | Goodnough, Robert, Badea, Adina, Geier, Curtis, Lynch, Kara L., LeSaint, Kathy T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104292/ https://www.ncbi.nlm.nih.gov/pubmed/33950934 http://dx.doi.org/10.1097/MD.0000000000025577 |
Ejemplares similares
-
Buprenorphine for Opioid Use Disorder in the Emergency Department: A Retrospective Chart Review
por: LeSaint, Kathy T., et al.
Publicado: (2020) -
A meta-analytic review of prevalence for Brugada ECG patterns and the risk for death
por: Quan, Xiao-Qing, et al.
Publicado: (2016) -
Frontier and hotspot evolution in Brugada syndrome: A bibliometric analysis from 2002 to 2022
por: Liu, Shixu, et al.
Publicado: (2023) -
A case report of Brugada-like ST-segment elevation probably due to coronary vasospasm
por: Yang, Lu, et al.
Publicado: (2018) -
Risk factors for cardiac events in patients with Brugada syndrome: A PRISMA-compliant meta-analysis and systematic review
por: Wu, Wenqing, et al.
Publicado: (2016)